๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris

โœ Scribed by Proby, Charlotte; Ohta, Takayuki; Nishifuji, Koji; Wheelock, Margaret J; Suzuki, Harumi; Koyasu, Shigeo; Gamou, Shinobu; Shimizu, Nobuyoshi; Nishikawa, Takeji; Amagai, Masayuki


Book ID
122046314
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
190 KB
Volume
16
Category
Article
ISSN
0923-1811

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Development of chimeric molecules for re
โœ C.M. Proby; T. Ota; H. Suzuki; S. Koyasu; S. Gamou; N. Shimizu; J.K. Wahl; M.J. ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 677 KB

Pemphigus vulgaris (PV) is an autoimmune blistering disease characterized by circulating pathogenic IgG antibodies against desmoglein 3 (Dsg3). The purpose of this study was to develop chimeric molecules for specific recognition and elimination of autoimmune B cells in PV. Mouse hybridoma cell lines

An HPLC/mass spectrometry platform for t
โœ Valerie Humblet; Preeti Misra; John V. Frangioni ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 376 KB

## Abstract The production of diseaseโ€targeted agents requires the covalent conjugation of a targeting molecule with a contrast agent or therapeutic, followed by purification of the product to homogeneity. Typical targeting molecules, such as small molecules and peptides, often have high chargeโ€toโ€